A Risk Factor Analysis of Prospective Symptomatic Haemorrhage in Adult Patients with Cerebral Cavernous Malformation
Overview
Neurosurgery
Psychiatry
Authors
Affiliations
Objective: The purpose of this study was to assess the risk factors of prospective symptomatic haemorrhage in a large series of adult patients with cerebral cavernous malformation (CM).
Methods: Three hundred twenty-six patients >18 years of age with 410 CMs were evaluated retrospectively. Symptomatic haemorrhage was defined as new clinical symptoms with radiographic features of haemorrhage. Clinical data and the characteristics of CM were analysed. MR appearance was divided into three groups according to Zabramski's classification.
Results: The overall haemorrhage rate of CM was 4.46% per lesion-year. The overall annual haemorrhage rate according to MR appearance was as follows: type I, 9.47%; type II, 4.74%; and type III, 1.43%. A multivariate analysis revealed that prior symptomatic haemorrhage (p<0.001) and MR appearance (p<0.001) were statistically significant. After multiple comparisons, type I (p<0.001) and type II (p=0.016) showed higher haemorrhage risk than type III. However, no significant difference in haemorrhage rate was observed between type I and type II (p=0.105). Other variables including female gender, age, location, multiplicity, hypertension, size and associated venous angioma were not significant. The haemorrhage rates based on risk factors were estimated at 3 years as follows: 33.77% in patients with prior haemorrhage versus 7.54% in patients without prior haemorrhage (p<0.001); type I, 27.62% vs type II, 15.44% vs type III, 5.38% (p<0.001).
Conclusions: Prior symptomatic haemorrhage and MR appearance could be related to prospective symptomatic CM haemorrhage in adults. A prospective multicentre observational study is necessary to confirm our results.
Outcomes after surgical and nonsurgical treatment of pediatric cerebral cavernous malformation.
Zhang H, Yu Q, Mao Z, Zhang L, Yu X Pediatr Investig. 2024; 8(2):126-134.
PMID: 38910851 PMC: 11193375. DOI: 10.1002/ped4.12435.
Li X, Jones P, Zhao M Sci Rep. 2024; 14(1):11022.
PMID: 38745042 PMC: 11094099. DOI: 10.1038/s41598-024-61851-4.
Li Z, Lu J, Liu M, Ma L, Quan K, Zhang H Int J Surg. 2024; 110(4):2217-2225.
PMID: 38668661 PMC: 11020047. DOI: 10.1097/JS9.0000000000001111.
Piccirilli E, Sestieri C, Di Clemente L, Delli Pizzi A, Colasurdo M, Panara V Radiol Med. 2023; 128(6):775-783.
PMID: 37184809 DOI: 10.1007/s11547-023-01642-5.
Chen B, Lahl K, Saban D, Lenkeit A, Rauschenbach L, Santos A Front Neurol. 2023; 13:1010170.
PMID: 36686509 PMC: 9847255. DOI: 10.3389/fneur.2022.1010170.